Electromed, Inc. Reports Higher Fiscal 2014 Third Quarter Revenues

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-month period ended March 31, 2014. Net revenues in the third quarter of fiscal 2014 were approximately $3.96 million, an approximately 24% increase compared to the same period of fiscal 2013. The Company reported a net loss of approximately $1,004,000 or $0.12 per basic and diluted share, for the third quarter of fiscal 2014, compared to a net loss of approximately $431,000, or $0.05 per basic and diluted share, for the same period last year.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC